Novo Nordisk flags patient data breach from some clinical trials in cyberattack

June 11 : Novo Nordisk said on Thursday it has identified a security incident in which certain information, including patient data from some clinical trials, was copied externally without authorization from its internal IT systems.The company, maker of the blockbuster weight-loss drug Wegovy, said it has laun


Business

Novo Nordisk flags patient data breach from some clinical trials in cyberattack

Novo Nordisk flags patient data breach from some clinical trials in cyberattack

FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. REUTERS/Tom Little/File Photo

Read a summary of this article on FAST.

Get bite-sized news via a new
cards interface. Give it a try.

Click here to return to FAST
Tap here to return to FAST

FAST

June 11 : Novo Nordisk said on Thursday it has identified a security incident in which certain information, including patient data from some clinical trials, was copied externally without authorization from its internal IT systems.

The company, maker of the blockbuster weight-loss drug Wegovy, said it has launched a probe with the assistance of external cybersecurity experts and is in contact with the relevant authorities.

“The incident affected a limited amount of information related to patients participating in some of our clinical trials,” Novo said in its statement, without disclosing what type of trials.

The potential categories of personal data affected may include patient ID, year of birth, sex and health or immunogenicity data among others, it added.Novo did not provide further details when contacted by Reuters.

Guess Word

Guess Word
Crack the word, one row at a time


Buzzword

Buzzword
Create words using the given letters


Mini Sudoku

Mini Sudoku
Tiny puzzle, mighty brain teaser


Mini Crossword

Mini Crossword
Small grid, big challenge


Word Search

Word Search
Spot as many words as you can


Show More


Show Less

In its statement, Novo said the information is not directly linked to any patients by name or other direct identifiers, and it does not consider the incident to enable any third party to identify participants in its clinical trials.

Knowledge of patient identity would require access to further information, which was not part of the incident, the company added.

The drugmaker said it does not view the incident as posing any immediate risks to patients, but advised that they report any unusual occurrences they believe could be linked to the incident.

The company has temporarily taken certain internal IT systems offline, and is working to bring the affected systems back online in a controlled and safe manner.

The company’s core business operations are not impacted and remain up and running, it added.

Source: Reuters

Sign up for our newsletters

Get our pick of top stories and thought-provoking articles in your inbox

Inbox

Get the CNA app

Stay updated with notifications for breaking news and our best stories

Get WhatsApp alerts

Join our channel for the top reads for the day on your preferred chat app

Whatsapp

Get bite-sized news via a new
cards interface. Give it a try.

Click here to return to FAST
Tap here to return to FAST

FAST

About The Author

Leave a Reply

Your email address will not be published. Required fields are marked *

About the Author

Easy WordPress Websites Builder: Versatile Demos for Blogs, News, eCommerce and More – One-Click Import, No Coding! 1000+ Ready-made Templates for Stunning Newspaper, Magazine, Blog, and Publishing Websites.

BlockSpare — News, Magazine and Blog Addons for (Gutenberg) Block Editor

Search the Archives

Access over the years of investigative journalism and breaking reports